$0.8901
-0.22-19.81%
At close: -
$0.8134
-0.08-8.62%
After Hours: 7:59 PM EDT
Comments
Loading...
CERo Therapeutics Hldgs Analyst Ratings and Price Targets | NASDAQ:CERO | Benzinga
CERo Therapeutics Holdings Inc has a consensus price target of $11 based on the ratings of 1 analysts. The high is $11 issued by D. Boral Capital on April 25, 2025. The low is $11 issued by D. Boral Capital on April 25, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on April 25, 2025, April 23, 2025, and April 22, 2025, respectively. With an average price target of $11 between D. Boral Capital, there's an implied 1252.35% upside for CERo Therapeutics Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
1calculated from analyst ratings
Analyst Ratings for CERo Therapeutics Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/25/2025 | Buy Now | 1252.35% | D. Boral Capital | Jason Kolbert44% | $11 → $11 | Maintains | Buy | Get Alert |
| 04/23/2025 | Buy Now | 1252.35% | D. Boral Capital | Jason Kolbert44% | $11 → $11 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 1252.35% | D. Boral Capital | Jason Kolbert44% | → $11 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for CERo Therapeutics Hldgs (CERO) stock?
The latest price target for CERo Therapeutics Hldgs (NASDAQ:CERO) was reported by D. Boral Capital on April 25, 2025. The analyst firm set a price target for $11.00 expecting CERO to rise to within 12 months (a possible 1252.35% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CERo Therapeutics Hldgs (CERO)?
The latest analyst rating for CERo Therapeutics Hldgs (NASDAQ:CERO) was provided by D. Boral Capital, and CERo Therapeutics Hldgs maintained their buy rating.
When was the last upgrade for CERo Therapeutics Hldgs (CERO)?
There is no last upgrade for CERo Therapeutics Hldgs
When was the last downgrade for CERo Therapeutics Hldgs (CERO)?
There is no last downgrade for CERo Therapeutics Hldgs.
When is the next analyst rating going to be posted or updated for CERo Therapeutics Hldgs (CERO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CERo Therapeutics Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CERo Therapeutics Hldgs was filed on April 25, 2025 so you should expect the next rating to be made available sometime around April 25, 2026.
Is the Analyst Rating CERo Therapeutics Hldgs (CERO) correct?
While ratings are subjective and will change, the latest CERo Therapeutics Hldgs (CERO) rating was a maintained with a price target of $11.00 to $11.00. The current price CERo Therapeutics Hldgs (CERO) is trading at is $0.81, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
